drugset / Trial / NCT07240922

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study

NCT07240922

Phase 4 Active not recruiting 600 enrolled The University of Hong Kong
RandomizedParallel-groupDouble-blindPrevention

Summary

This study will provide novel insight into the effects of repeat influenza vaccination with Flublok and FluMist on the strength and breadth of immune responses to influenza, the mechanisms underlying heterogeneity in vaccine response and vaccine failure, and biological factors that could explain variation in influenza vaccine effectiveness.

Timeline

Start
2025-10-01
Primary completion
2030-10-01
Completion
2030-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject FluMist Vaccine 0.2 ml Intranasal
Subject Flublok Vaccine 0.5 ml Other

Indications